Tradestie Institutional Equity Comparison Engine

NUVB vs ARDX โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-20 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

ARDX Overall Edge

ARDX Captures Institutional Edge (4โ€“0 Pillars ยท 6โ€“4 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Ardelyx, Inc. (ARDX) driven by superior Valuation, Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, NUVB trades at N/M Forward P/E with -61.2% operating margin (+242.6% YoY revenue) versus ARDX at 18.9x Forward P/E and -7.7% operating margin (+15.7% YoY). In options structure, NUVB sits in BREAKDOWN (26th %ile IV; Dealer Gamma Walls on Pro) against ARDX sits in BREAKDOWN (14th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner ARDX
NUVB N/M vs ARDX 18.9x Fwd P/E
Growth & Margin Winner ARDX
Op Margin -61.2% vs -7.7% ยท YoY +242.6% vs +15.7%
Momentum & Technical Winner ARDX
1Y -46.9% vs -46.3% ยท 52W Pos 2% vs 3%
Options & Structure Winner ARDX
BREAKDOWN (26th %ile IV) vs BREAKDOWN (14th %ile IV)
NUVB NYSE
Nuvation Bio Inc.
Pharmaceutical Preparations
$3.80
-0.26% 1D
Market Cap $1.3B
1M Return -19.15%
1Y Return -46.85%
Forward P/E N/M
Unified AI Score
61.0 / 100 BUY
Tech 53.0 Fund 61.0 Flow 67.0 Mom 64.0
ARDX NASDAQ
Ardelyx, Inc.
Pharmaceutical Preparations
$2.99
-2.29% 1D
Market Cap $769.2M
1M Return -6.56%
1Y Return -46.32%
Forward P/E 18.9x
Unified AI Score
57.7 / 100 HOLD
Tech 43.0 Fund 54.0 Flow 70.0 Mom 54.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: NUVB -46.85% ARDX -46.32% Spread: +0.53 pp (ARDX Lead)

Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant Revenue ($B) & Operating Margin (%)
Period NUVB Revenue ARDX Revenue NUVB Op. Margin ARDX Op. Margin Margin Edge
FY2018 N/A $0M N/A -3488.6% ARDX
FY2019 N/A $10M N/A -1728.1% ARDX
FY2020 N/A $10M N/A -1199.0% ARDX
FY2021 N/A $10M N/A -1528.6% ARDX
FY2022 N/A $50M N/A -122.2% ARDX
FY2023 N/A $120M N/A -50.8% ARDX
FY2024 $10M $330M -7527.3% -8.4% ARDX
FY2025 $60M $410M -338.7% -10.1% ARDX

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: NUVB (4) vs ARDX (6)
Institutional Metric NUVB ARDX Criterion Row Winner
Market Capitalization Scale $1.3B $769.2M Larger Scale NUVB
Trailing P/E Ratio Valuation N/M 52.1x Lower Multiple ARDX
Forward P/E Ratio Valuation N/M 18.9x Lower Multiple ARDX
Revenue Growth (YoY) Growth +242.6% +15.7% Higher Growth NUVB
Operating Margin (TTM) Profitability -61.2% -7.7% Higher Margin ARDX
Net Profit Margin Profitability -67.4% -11.8% Higher Margin ARDX
Return on Equity (ROE) Capital Efficiency -49.1% -34.8% Higher ROE ARDX
52-Week Range Position Momentum 2% ($4โ€“$10) 3% ($3โ€“$8) Stronger Trend ARDX
Beta / 30D Volatility Risk Regime 1.52ฮฒ ยท 55% Vol 0.93ฮฒ ยท 56% Vol Lower Realized Risk NUVB
Unified Institutional Score Composite Signal 61.0 / 100 (BUY) 57.7 / 100 (HOLD) Higher Composite NUVB

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full NUVB vs ARDX Buy Guide
NUVB BREAKDOWN
105d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 26th %ile
IV Regime Balanced (25thโ€“60th %ile)
Live NUVB Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
ARDX BREAKDOWN
140d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 14th %ile
IV Regime Compressed (<25th %ile)
Live ARDX Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither NUVB nor ARDX registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.